09 November 2011

The popularity of dermal fillers and cosmetic surgery treatments has led one product manufacturer to invest $12m in a new research and development facility. California-based Allergan, known around the world for its line and wrinkle treatment Botox, has announced it is to build a new 100,000 sq ft base in New Jersey. The company has yet to choose a specific site, but Allergan said it expects to create 400 new jobs in the state over the next five years.Allergan spokeswoman, Cathy Taylor, told The Star-Ledger newspaper that the plan is to have the new facility close to the company's current site in Bedminster, which employs 20 people. She said: "We conducted an extensive search process initially looking at all areas outside of California, but quickly landed on (New Jersey) due to the pool of talent in the pharma/device industry in the region, as well as the proximity to medical centres and universities." Allergan recently announced its third-quarter figures, unveiling profits of $250m (156m) during the three months to September 30.